Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014


ON Helix

02 Jul 2014 - 02 Jul 2014 - Cambridge, UK



Bookmark and Share


The ‘ON Helix’ translational research conference will bring together key experts from industry and academia to discuss how we can help ground-breaking primary research successfully transition into treatments for patients.

The topics covered during this one day event will centre around:

  • The UK business environment 
  • Research funding
  • Scientific and clinical research excellence 
  • How ideas and early stage inventions are turned into innovative health treatments 

The high profile global leaders that will give presentations and/or join in as part of panel discussions include:

  • Dr. Mene Pangalos, Executive Vice president Innovative Medicines and Early Research at AstraZeneca
  • Sir Mike Rawlins, Chairman of the EAHSN and President of the Royal Society of Medicine
  • Sir Gregory Winter, Master, Trinity College, Cambridge and founder of Bicycle Therapeutics Ltd
  • Rob Pinnock, Director Scientific Liaison, UK, Ireland, Portugal and Spain, Merck Sharp & Dohme 
  • Hermann Hauser, serial Cambridge entrepreneur and venture capitalist 
  • and other highly regarded and respected personalities form industry and academia

 This event is aimed at:

  • Biotech and healthcare company, senior executives
  • Academic technology transfer executives
  • Pharma business and research development directors
  • Life science investors
  • Technical and professional service providers

At the end of the talk and panel discussions, there will be a drinks reception and plenty of time for networking and partnering.



Further information
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!